Scientech Research’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
Scientech Research's GPCR Position: Q2 2026 in Review
Scientech Research sold out of Structure Therapeutics (GPCR) in Q2 2026, closing a stake of 6,958 shares — an estimated $335K sold.
Scientech Research first reported a position in GPCR in Q2 2024 and held it in 2 quarters. The position peaked at $738K in Q2 2024. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.
- Scientech Research reported no remaining Structure Therapeutics position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 6,958 Structure Therapeutics shares in Q2 2026, an estimated $335K.
- Scientech Research first reported a position in Structure Therapeutics in Q2 2024 and held it in 2 quarters.
- Scientech Research's Structure Therapeutics position peaked at $738K in Q2 2024.
- 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.